New Mountain Capital
Matthew Holt has been with New Mountain Capital since 2001, where he currently serves as Managing Director. Matt led the New Mountain Capital investment in NuSil and continues to serve as the lead director for the firm. Matt’s investment experience in the overlapping areas of healthcare and specialty chemicals has helped shape NuSil’s long-term strategy. He joined the NuSil board in 2011.
Prior to New Mountain, Matt worked in the Mergers and Acquisitions Group at Lehman Brothers, where he helped evaluate and execute a number of strategic transactions across various industries. In addition to his role at NuSil, he is also a director of Avantor, Ikaria, and Bellerophon.
He holds an A.B. with honors in English and American Literature and Language from Harvard College.